GLYCOBIDUO Trademark

Trademark Overview

On Thursday, May 1, 2025, a trademark application was filed for GLYCOBIDUO with the United States Patent and Trademark Office. The USPTO has given the GLYCOBIDUO trademark a serial number of 99166463. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, August 12, 2025. This trademark is owned by OBI PHARMA, INC.. The GLYCOBIDUO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific laboratory services; Scientific research; Chemical analysis; Chemical research; Scientific research in the field of genetics; Biological research; Medical research; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Providing laboratory research services in the field of gene expression, namely, cancer biology; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Providing information about medical research in the field of cancer, oncology; Medical research in the field of oncology; Chemical research services; Medical research services; Scientific research and development; Pharmaceutical research and development; Chemical research and analysis; Biological research and analysis; Technical research in the field of pharmaceutical studies
glycobiduo

General Information

Serial Number99166463
Word MarkGLYCOBIDUO
Filing DateThursday, May 1, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, August 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 2, 2025

Trademark Statements

Description of MarkThe mark consists of the stylized wording "GLYC OBI DUO". The wording "GLYC" and "DUO" are in black and "OBI" is in teal. There is a curved teal line below "OBI". The color white represents background, outlining, shading and/or transparent areas and is not part of the mark.
Indication of Colors claimedThe color(s) black and teal is/are claimed as a feature of the mark.
Goods and ServicesScientific laboratory services; Scientific research; Chemical analysis; Chemical research; Scientific research in the field of genetics; Biological research; Medical research; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Providing laboratory research services in the field of gene expression, namely, cancer biology; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Providing information about medical research in the field of cancer, oncology; Medical research in the field of oncology; Chemical research services; Medical research services; Scientific research and development; Pharmaceutical research and development; Chemical research and analysis; Biological research and analysis; Technical research in the field of pharmaceutical studies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 1, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOBI PHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City 115011
TW

Trademark Events

Event DateEvent Description
Thursday, May 1, 2025NEW APPLICATION ENTERED
Thursday, May 1, 2025APPLICATION FILING RECEIPT MAILED
Monday, June 30, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, June 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 8, 2025ASSIGNED TO EXAMINER
Monday, July 28, 2025EXAMINERS AMENDMENT E-MAILED
Monday, July 28, 2025EXAMINERS AMENDMENT -WRITTEN
Monday, July 28, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 28, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 28, 2025EXAMINER'S AMENDMENT ENTERED

Related Keywords

glycobiduo research field medical scientific cancer services chemical development analysis pharmaceutical